Catheter-Related Bloodstream Infections,Part II: Specific Pathogens and Prevention

Christensen G.D. , Bisno A.L. , Parisi J.T. . Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med. 1982; 96: 1–10.

Winston D.J. , Dudnick D.V. , Chapin M. . Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med. 1983; 143: 32–36.

Sattler F.R. , Foderaro J.B. , Aber R.C. . Staphylococcus epidermidis bacteremia associated with vascular catheters: an important cause of febrile morbidity in hospitalized patients. Infect Control. 1984; 5: 279–283.

Raad I. , Davis S. , Khan A. . Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol. 1992; 13: 215–221.

Rabinovich S. , Smith I.M. , January L.E. . The changing patterns of bacterial endocarditis. Med Clin North Am. 1968; 52: 1091–1101.

Lerner P.I. , Weinstein L. . Infective endocarditis in the antibiotic era. N Engl J Med. 1966; 274: 388–393.

Mylotte J.M. , McDermott C. , Spooner J.A. . Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987; 9: 891–907.

Nolan C.M. , Beaty H.N. . Staphylococcus aureus bacteremia: current clinical patterns. Am J Med. 1976; 60: 495–500.

Iannini P.B. , Crossley K. . Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. Ann Intern Med. 1976; 84: 558–560.

Bayer A.S. , Tillman D.B. , Concepcion N. . Clinical value of teichoic acid antibody titers in the diagnosis and management of the staphylococcemias. West J Med. 1980; 132: 294–300.

Ehni W.F. , Reller L.B. . Short-course therapy for catheter-associated Staphylococcus aureus bacteremia. Arch Intern Med. 1989; 149: 533–536.

Jernigan J.A. , Farr B.M. . Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med. 1993; 119: 304–311.

Gold H.S. , Karchmer A.W. . Catheter-associated Staphylococcus aureus bacteremia. Hosp Pract (Off Ed). 1996; 31: 133–137, 142-144, 150.

Malanoski G.J. , Samore M.H. , Pefanis A. . Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med. 1995; 155: 1161–1166.

Fowler V.G. Jr. , Sanders L.L. , Sexton D.J. . Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998; 27: 478–486.

Capdevila J.A. , Segarra A. , Planes A. . Long-term follow-up of patients with catheter related sepsis (crs) treated without catheter removal. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 1995; San Francisco, Calif. Abstract J3.

Raad I.I. , Sabbagh M.F. . Optimal duration of therapy for catheter-related Staphylo-coccus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis. 1992; 14: 75–82.

Libman H. , Arbeit R.D. . Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med. 1984; 144: 541–545.

Jacobson M.A. , Gellermann H. , Chambers H. . Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med. 1988; 85: 172–176.

Mortara L.A. , Bayer A.S. . Staphylococcus aureus bacteremia and endocarditis. Infect Dis Clin North Am. 1993; 7: 53–68.

Schrenzel J. , Schockmel G. , Bregenzer T. . Severe staphylococcal infections: a randomized trial comparing quinolone plus rifampin (IV then PO) with conventional IV therapy. In: Proceedings of the 36th annual meeting of the Infectious Diseases Society of America; November 12-15, 1998; San Francisco, Calif. Abstract A93.

Dworkin R.J. , Lee B.L. , Sande M.A. . Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet. 1989; 2: 1071–1073.

Heldman A.W. , Hartert T.V. , Ray S.C. . Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996; 101: 68–76.

Acocella G. . Pharmacokinetics and metabolism of rifampin in humans. Rev Infect Dis. 1983; 5(suppl 3): S428–S432.

Farr B.M. . Rifamycins. In: Mandell G.L. , Bennett J.E. , Dolin R. , eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000: 348–361.

Maki D.G. , Mermel L.A. . Infections due to infusion therapy. In: Bennett J.V. , Brachman P.S. , eds. Hospital Infections. Philadelphia, Pa: Lippincott-Raven; 1998: 689–724.

Seifert H. . Catheter-related infections due to Gram-negative bacilli. In: Seifert H. , Jansen B. , Farr B.M. , eds. Catheter-Related Infections. New York, NY: M. Dekker; 1997: 111–138.

Mermel L.A. , Farr B.M. , Sherertz R.J. . Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32: 1249–1272.

Pena C. , Pujol M. , Ardanuy C. . An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J Hosp Infect. 2001; 47: 53–59.

Martino R. , Gomez L. , Pericas R. . Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis. 2000; 19: 320–323.

Friedman N. , Korman T. , Fairley C. . Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect. 2002; 45: 47.

Martino R. , Santamaria A. , Munoz L. . Bacteremia by gram-negative bacilli in patients with hematologic malignancies: comparison of the clinical presentation and outcome of infections by enterobacteria and non-glucose-fermenting gram-negative bacilli. Acta Haematol. 1999; 102: 7–11.

Rose H.D. . Venous catheter-associated candidemia. Am J Med Sci. 1978; 275: 265–269.

Rex J.H. , Bennett J.E. , Sugar A.M. . A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia: Candidemia Study Group and the National Institute. N Engl J Med. 1994; 331: 1325–1330.

Anaissie E.J. , Vartivarian S.E. , Abi-Said D. . Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med. 1996; 101: 170–176.

Dato V.M. , Dajani A.S. . Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J. 1990; 9: 309–314.

Nguyen M.H. , Peacock J.E. Jr. , Tanner D.C. . Therapeutic approaches in patients with candidemia: evaluation in a multicenter prospective observational study. Arch Intern Med. 1995; 155: 2429–2435.

Raad I. . Intravascular-catheter-related infections. Lancet. 1998; 351: 893–898.

Rex J.H. , Walsh T.J. , Sobel J.D. . Practice guidelines for the treatment of candidiasis: Infectious Diseases Society of America. Clin Infect Dis. 2000; 30: 662–678.

Nucci M. , Anaissie E. . Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis. 2002; 34: 591–599.

Nucci M. , Colombo A.L. , Silveira F. . Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol. 1998; 19: 846–850.

Nucci M. , Silveira M.I. , Spector N. . Risk factors for death among cancer patients with fungemia. Clin Infect Dis. 1998; 27: 107–111.

Anaissie E.J. , Rex J.H. , Uzum O. . Predictors of adverse outcome in cancer patients with candidemia. Am J Med. 1998; 104: 238–245.

Luzzati R. , Amalfitano G. , Lazzarini L. . Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis. 2000; 19: 602–607.

Thyrault M. , Gachot B. , Chastang C. . Septic shock in patients with the acquired immunodeficiency syndrome. Intensive Care Med. 1997; 23: 1018–1023.

Annane D. , Sebille V. , Troche G. . A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000; 283: 1038–1045.

Nucci M. , Anaissie E. . Revisiting the source of candidemia: skin or gut? Clin Infect Dis. 2001; 33: 1959–1967.

Mermel L.A. , McCormick R.D. , Springman S.R. . The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular sub-typing. Am J Med. 1991; 91(3B): 197S–205S.

Bjornson H.S. , Colley R. , Bower R.H. . Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery. 1982; 92: 720–727.

Blot F. , Chachaty E. , Raynard B. . Mechanisms and risk factors for infection of pulmonary artery catheters and introducer sheaths in cancer patients admitted to an intensive care unit. J Hosp Infect. 2001; 48: 289–297.

Maki D.G. , Ringer M. , Alvarado C.J. . Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991; 338: 339–343.

Sheehan G. , Leicht K. , O'Brien M. . Chlorhexidine versus povidone-iodine as cutaneous antisepsis for prevention of vascular-catheter infection. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; October 17-20, 1993; New Orleans, La. Abstract 1616.

Mimoz O. , Pieroni L. , Lawrence C. . Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med. 1996; 24: 1818–1823.

Humar A. , Ostromecki A. , Direnfeld J. . Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis. 2000; 31: 1001–1007.

Maki D.G. , Knasinski V. , Narans L.L. . A randomized trial of a novel 1% chlorhexidine-75% alcohol tincture vs 10% povidone-iodine for cutaneous disinfection with vascular catheters. In: Program and abstracts of the 31st Annual Society for Healthcare Epidemiology of America Meeting; April 1-3, 2001; Toronto, Ontario. Abstract A142.

Garland J.S. , Buck R.K. , Maloney P. . Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J. 1995; 14: 510–516.

Meffre C. , Girard R. , Hajjar J. . Povidone-iodine versus alcoholic chlorhexidine for disinfection of the insertion site of peripheral venous catheters: results of a multicenter randomized trial. Infect Control Hosp Epidemiol. 1996; 17(5 suppl 2): A64. Abstract.

Cobbett S. , LeBlanc A. . IV site infection: a prospective, randomized clinical trial comparing the efficacy of three methods of skin antisepsis. J Intraven Nurs. 1999; 15: 48–49. Abstract.

Sesso R. , Barbosa D. , Leme I.L. . Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol. 1998; 9: 1085–1092.

Zakrzewska-Bode A. , Muytjens H.L. , Liem K.D. . Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect. 1995; 31: 189–193.

Crnich C.J. , Maki D.G. . The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis. 2002; 34: 1232–1242.

Wille J.C. , Blusse van Oud Albas A. , Thewessen E.A. . A comparison of two transparent film-type dressings in central venous therapy. J Hosp Infect. 1993; 23: 113–121.

Maki D.G. , Ringer M. . Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA. 1987; 258: 2396–2403.

Madeo M. , Martin C.R. , Turner C. . A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive Crit Care Nurs. 1998; 14: 187–191.

Hanazaki K. , Shingu K. , Adachi W. . Chlorhexidine dressing for reduction in microbial colonization of the skin with central venous catheters: a prospective randomized controlled trial. J Hosp Infect. 1999; 42: 165–168.

Garland J.S. , Alex C.P. , Mueller C.D. . A randomized trial comparing povidone-iodine to chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001; 107: 1431–1436.

Maki D.G. , Mermel L.A. , Kluger D.M. . The efficacy of a chlorhexidine-impregnated sponge (biopatch) for the prevention of intravascular catheter related infection: a prospective, randomized, controlled, multicenter trial. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 2000; Toronto, Ontario. Abstract 1430.

Maki D.G. , Cobb L. , Garman J.K. . An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med. 1988; 85: 307–314.

Bonawitz S.C. , Hammell E.J. , Kirkpatrick J.R. . Prevention of central venous catheter sepsis: a prospective randomized trial. Am Surg. 1991; 57: 618–623.

Flowers RH III , Schwenzer K.J. , Kopel R.F. . Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: a randomized, controlled trial. JAMA. 1989; 261: 878–883.

Babycos C.R. , Barrocas A. , Webb W.R. . A prospective randomized trial comparing the silver-impregnated collagen cuff with the bedside tunneled subclavian catheter. JPEN J Parenter Enteral Nutr. 1993; 17: 61–63.

Smith H.O. , DeVictoria C.L. , Garfinkel D. . A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection. Gynecol Oncol. 1995; 58: 92–100.

Mermel L.A. , Stolz S.M. , Maki D.G. . Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis. 1993; 167: 920–924.

Moss H.A. , Tebbs S.E. , Faroqui M.H. . A central venous catheter coated with benzalkonium chloride for the prevention of catheter-related microbial colonization. Eur J Anaesthesiol. 2000; 17: 680–687.

Jaeger K. , Osthaus A. , Heine J. . Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients. Chemotherapy. 2001; 47: 50–55.

Veenstra D.L. , Saint S. , Saha S. . Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999; 281: 261–267.

Mermel L.A. . Prevention of intravascular catheter-related infections. Ann Intern Med. 2000; 132: 391–402.

Raad I. , Darouiche R. , Hachem R. . The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis. 1996; 173: 418–424.

Darouiche R.O. , Raad I.I. , Heard S.O. . A comparison of two antimicrobial-impregnated central venous catheters: Catheter Study Group. N Engl J Med. 1999; 340: 1–8.

Raad I. , Darouiche R. , Dupuis J. . Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997; 127: 267–274.

Raad I.I. , Hackett B. , Hanna H. . Use of antibiotic impregnated catheters associated with significant decrease in nosocomial bloodstream infections in critically ill cancer patients. In: Proceedings of the 10th Annual Meeting of the Society of Healthcare Epidemiology of America. Atlanta, Ga: March 5-9, 2000. Abstract S-W3-05.

Marik P.E. , Abraham G. , Careau P. . The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med. 1999; 27: 1128–1131.

Sampath L. , Tambe S. , Modak S. . Comparison of the efficacy of antiseptic and antibiotic catheters impregnated on both their luminal and outer surfaces. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco, Calif. Abstract 1917.

Goldschmidt H. , Hahn U. , Salwender H.J. . Prevention of catheter-related infections by silver coated central venous catheters in oncological patients. Zentralbl Bakteriol. 1995; 283: 215–223.

Bach A. , Eberhardt H. , Frick A. . Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med. 1999; 27: 515–521.

Boswald M. , Lugauer S. , Regenfus A. . Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection. 1999; 27(suppl 1): S56–S60.

Carbon R.T. , Lugauer S. , Geitner U. . Reducing catheter-associated infections with silver-impregnated catheters in long-term therapy of children. Infection. 1999; 27(suppl 1): S69–S73.

Parkhouse DAFH , Hocking G.R. , Shaikh L.S. . Advanced catheter related infection and line sepsis following the use of Ventex central venous catheters in the critically ill. Crit Care Med. 2000; 28(12 suppl): A54. Abstract.

Bong J.J. , Kite P. , Wilcox M.H. . Efficacy of silver iontophoretic central venous catheters in preventing catheter-related bloodstream infection amongst high-risk patients: a randomized controlled trial. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, Ill; December 16-19, 2001. Abstract K-1425.

Ibanez-Nolla J.J. , Corral M.L. , Nolla M. . A randomized study using oligon vantex central venous catheters (cvc) to reduce bacterial colonization. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, Ill; December 16-19, 2001. Abstract K-1428.

Cappello M. , De Pauw L. , Bastin G. . Central venous access for haemodialysis using the Hickman catheter. Nephrol Dial Transplant. 1989; 4: 988–992.

Dryden M.S. , Samson A. , Ludlam H.A. . Infective complications associated with the use of the Quinton “Permcath” for long-term central vascular access in haemodialysis. J Hosp Infect. 1991; 19: 257–262.

Groeger J.S. , Lucas A.B. , Thaler H.T. . Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993; 119: 1168–1174.

Crnich C.J. , Maki D.G. . The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis. 2002; 34: 1362–1368.

Groeger J.S. , Lucas A.B. , Coit D. . A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg. 1993; 218: 206–210.

Graham D.R. , Keldermans M.M. , Klemm L.W. . Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med. 1991; 91(3B): 95S–100S.

Duerksen D.R. , Papineau N. , Siemens J. . Peripherally inserted central catheters for parenteral nutrition: a comparison with centrally inserted catheters. JPEN J Parenter Enteral Nutr. 1999; 23: 85–89.

Cowl C.T. , Weinstock J.V. , Al-Jurf A. . Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters. Clin Nutr. 2000; 19: 237–243.

Janes M. , Kalyn A. , Pinelli J. . A randomized trial comparing peripherally inserted central venous catheters and peripheral intravenous catheters in infants with very low birth weight. J Pediatr Surg. 2000; 35: 1040–1044.

Yamamoto A.J. , Solomon J.A. , Soulen M.C. . Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol. 2002; 13: 77–81.

Trerotola S.O. , Johnson M.S. , Shah H. . Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection: a randomized study. Radiology. 1998; 207: 491–496.

O'Grady N.P. , Alexander M. , Dellinger E.P. . Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002; 51(RR-10): 1–29.

Rackoff W.R. , Weiman M. , Jakobowski D. . A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr. 1995; 127: 147–151.

Daghistani D. , Horn M. , Rodriguez Z. . Prevention of indwelling central venous catheter sepsis. Med Pediatr Oncol. 1996; 26: 405–408.

Schwartz C. , Henrickson K.J. , Roghmann K. . Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol. 1990; 8: 1591–1597.

Carratala J. , Niubo J. , Fernandez-Sevilla A. . Randomized, double-blind trial of an antibiotic-lock technique for prevention of Gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother. 1999; 43: 2200–2204.

Henrickson K.J. , Axtell R.A. , Hoover S.M. . Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol. 2000; 18: 1269–1278.

Garland J.S. , Henrickson K.J. , Maki D.G. . A prospective randomized trial of vancomycin-heparin lock for prevention of catheter-related bloodstream infection in an NNICU. In: Program and abstracts of the 2002 Annual Meeting of the Pediatric Academic Societies; May 4-7, 2002; Baltimore, Md. Abstract 1734.

Messing B. , Man F. , Colimon R. . Antibiotic lock technique is an effective treatment of bacterial catheter related sepsis during parenteral nutrition. Clin Nutr. 1990; 9: 220–227.

Messing B. , Peitra-Cohen S. , Debure A. . Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 1988; 12: 185–189.

Rao J.S. , O'Meara A. , Harvey T. . A new approach to the management of Broviac catheter infection. J Hosp Infect. 1992; 22: 109–116.

Krzywda E.A. , Andris D.A. , Edmiston C.E. Jr. ,. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol. 1995; 16: 596–598.

Longuet P. , Douard M.C. , Arlet G. . Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis. 2001; 32: 1776–1783.

Domingo P. , Fontanet A. , Sanchez F. . Morbidity associated with long-term use of totally implantable ports in patients with AIDS. Clin Infect Dis. 1999; 29: 346–351.

Spafford P.S. , Sinkin R.A. , Cox C. . Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep. 1994; 44: 1–13.

Sieradzki K. , Roberts R.B. , Serur D. . Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin. Lancet. 1998; 351: 880–881.

Hiramatsu K. , Aritaka N. , Hanaki H. . Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997; 350: 1670–1673.

Hiramatsu K. , Aritaka A.N. , Hanaki H. . Interim guidelines for prevention and control of staphylococcal infections associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep. 1997; 46: 626–628.

Smith T.L. , Pearson M.L. , Wilcox K.R. . Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999; 340: 493–501.

Sieradzki K. , Roberts R.B. , Haber S.W. . The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med. 1999; 340: 517–523.

Raad I. , Buzaid A. , Ryne J. . Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis. 1997; 25: 149–151.

Bleyer A. , Mason L. , Raad I. . A randomized, double-blind trial comparing minocycline/edta vs heparin as flush solutions for hemodialysis catheters. In: Program and abstracts of the Fourth Decennial Conference Program Committee; March 5-9, 2000; Atlanta, Ga. Abstract P-S1-31.